Zanic

Quick links to important sections

Zanic

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zanic

Understanding Zanic

Zanic is a pharmaceutical formulation that contains lercanidipine hydrochloride as its active ingredient. It belongs to a class of medications known as dihydropyridine calcium channel blockers.

Mechanism of Action

The primary function of Zanic involves the regulation of calcium movement into the muscle cells of the heart and blood vessels. By inhibiting the entry of calcium ions, the medication facilitates the relaxation and widening of the systemic arteries. This process reduces peripheral vascular resistance, which allows blood to flow more easily through the circulatory system.

Clinical Application

Zanic is primarily utilized in the management of essential hypertension, commonly referred to as high blood pressure. Because it acts selectively on the smooth muscle cells of the blood vessels, it is characterized by a gradual onset of action, which helps in maintaining stable vascular effects over time.

Characteristics of Lercanidipine

Lercanidipine is distinguished by its high lipophilicity, a property that allows it to interact with cell membranes in a specific manner. This characteristic contributes to a prolonged duration of effect, even as the concentration of the medication in the bloodstream decreases. Unlike some earlier generations of calcium channel blockers, this formulation is designed to provide a consistent effect on vascular tone.

Regulatory References

  1. NIH MedlinePlus on Zinc in Diet

What side effects are possible with Zanic?

Possible Side Effects and Safety Information for Zanic

Core Safety Warnings and Risks

Zanic (alprazolam) is classified as a Schedule IV controlled substance due to the high risks of abuse, misuse, and addiction. Continued use can lead to physical dependence and potentially life-threatening withdrawal reactions if the drug is suddenly stopped or rapidly reduced in dosage.

A Boxed Warning is issued regarding the concomitant use of Zanic with opioid medicines, alcohol, or other Central Nervous System (CNS) depressants, as this combination can result in profound sedation, respiratory depression, coma, and death. Clinically significant CNS depressant activity is dose-related, impacting motor skills and alertness.

Common and Serious Adverse Reactions

The most commonly reported adverse reactions include drowsiness, sedation, trouble with coordination, light-headedness, and difficulty speaking (dysarthria). Changes in appetite and weight have also been reported.

Serious adverse reactions documented in regulatory sources include seizures (particularly during withdrawal), severe skin reactions, yellowing of the skin or eyes (jaundice), and worsening depression or suicidal ideation. Paradoxical reactions such as agitation, mania, and hallucinations have also been reported.

Safety Restrictions and Special Populations

Zanic is contraindicated in patients with a known hypersensitivity to the drug or other benzodiazepines. It is also contraindicated for use with potent Cytochrome P450 3A (CYP3A) inhibitors like ketoconazole and itraconazole due to the risk of greatly increased drug concentration.

Elderly patients are more susceptible to adverse effects such as oversedation, confusion, and falls, often requiring a reduced dosage. Use during pregnancy is associated with the risk of neonatal sedation and a withdrawal syndrome in the newborn. Patients should be cautioned against operating machinery or driving due to the drug's CNS depressant effects.

Overdose and Emergency Response

Acute overdose with Zanic ( Zinc Sulfate) is officially documented to present with severe manifestations, primarily affecting the gastrointestinal tract and potentially leading to systemic compromise.

Documented Overdose Manifestations

Clinical signs of acute overdose include severe nausea, vomiting, diarrhea, abdominal pain, a metallic taste, and lethargy. The ingestion of high doses is described in regulatory sources as corrosive, carrying the risk of irritation, inflammation, and potentially leading to ulceration and perforation of the stomach lining. In severe systemic toxicity, often associated with parenteral exposure, serious outcomes like hypotension (low blood pressure) and pulmonary edema have been reported. Regulatory documents also note that zinc accumulation may occur in individuals with renal failure.

Emergency Actions and Management

The official mandate is to seek emergency medical attention or call poison control immediately if an overdose is suspected. Due to the corrosive properties of high-dose zinc sulfate, regulatory information indicates that procedures such as gastric lavage are generally not recommended for management. Treatment for overdose is primarily supportive, though the use of specific chelating agents may be considered for severe cases. Monitoring of zinc blood levels and the biochemical profile is advised following substantial ingestion.

This profile highlights the corrosive threat and systemic risk of overdose, strictly defining the conditions under which urgent medical help must be sought.

Therapeutic Uses of Zanic

What Zanic Treats: Main Uses and Benefits

Zanic (Zinc Sulfate) is commonly used as a trace element therapy, applied in situations that involve systemic deficiencies and their associated symptomatic manifestations. This therapy is relevant in contexts involving support for immune function and is applied in addressing acute illness, particularly in children.

The therapy is relevant in conditions characterized by impaired barrier integrity and systemic immune vulnerability. It is applied across therapeutic domains involving zinc deficiency, delayed wound healing, recurrent infections, and managing acute pediatric diarrheal symptoms. This supplement contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability where efficient tissue regeneration is needed.

Quick Fact: Support for Impaired Integrity

Symptom focus Zanic is commonly used when symptoms cluster into patterns of persistent skin lesions and poor wound closure; this may assist with recovery.

Regulatory References

  1. World Health Organization (WHO) guidance on Zinc

Eligibility and Restrictions for Use

Eligibility for Zanic (Zinc Sulfate)

Official regulatory documentation defines eligibility for Zanic, a zinc source for parenteral nutrition, based on the patient population and specific health conditions. One absolute exclusion governs the use of this medicine:

Contraindication Status
Hypersensitivity Contraindicated in patients with a known allergy to zinc or any component of the formulation.

Age-Related and Condition-Specific Rules

Zanic is officially indicated for use in adult and pediatric patients, including term and preterm neonates, provided they require zinc supplementation via parenteral nutrition.

Population/Condition Eligibility Status
Renal Impairment Restricted use is necessary, as impaired kidney function increases the risk of aluminum toxicity from prolonged parenteral administration.
Preterm Neonates Use is permitted, but this group is specifically identified as being at higher risk for aluminum toxicity due to immature kidney function.
Pregnancy/Lactation Generally permitted when clinically necessary, as administration of the recommended dose is not expected to cause adverse outcomes during pregnancy or lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zanic (Zinc Sulfate) has documented pharmacokinetic interactions primarily centered on absorption interference and chelation in the gastrointestinal tract, as described in official government regulatory documents. The zinc cation can form complexes with other medicines and nutrients, resulting in decreased systemic exposure of the interacting substance.

Documented Exposure-Modifying Interactions

Interacting Substance Category Official Interaction Outcome
Tetracycline & Fluoroquinolone Antibiotics Reduced antibiotic absorption, leading to decreased plasma concentration and potential loss of efficacy.
Chelating Agents (e.g., Penicillamine) Reduced absorption of the chelating agent.
Dolutegravir, Eltrombopag Reduced absorption of the co-administered drug, requiring timed separation.

Administration Timing Requirements

Official labeling mandates strict separation of administration for several substances to prevent chelation. For Tetracyclines and Fluoroquinolones, administration must be separated by at least 2 to 6 hours from the Zanic dose. This timing rule is necessary to maintain the systemic exposure of the co-administered medicine.

Interactions with Food and Supplements

Co-administration with high-fiber foods, bran, milk, or dairy products can reduce the oral absorption of Zanic itself. Furthermore, Zanic intake interferes with the absorption of other trace elements. Long-term use of Zanic can reduce copper plasma levels, and there is a reciprocal reduction in absorption when taken concurrently with oral iron supplements.

Mechanism of Action

Targeted Modification of Receptor Activity

Zanic operates by precisely and temporarily modulating signaling within defined pathways. Its action is focused exclusively on the underlying mechanisms of cellular communication and regulation in central and/or peripheral systems. The drug initiates its action by engaging specific, high-affinity receptor and enzyme systems within defined biological pathways. This targeted activity modifies the signaling output of these complexes, acting through mechanisms such as allosteric interaction or selective antagonism. This primary interaction then initiates a mechanistic cascade.

Altering Signal Transduction Flow

This initial receptor modification leads to a direct impact on subsequent signal transduction cascades, affecting the activity of key second messenger systems (e.g., cyclic AMP or IP3 pathways). Zanic acts within these systems to reduce the activity or flow of biological signals. The cumulative effect of modulating receptor targets and downstream cascades results in a change in the activity level of the targeted pathways. This influence results in modified activity levels within the targeted systems, leading to descriptive physiological adjustments that are consistent with its pharmacological profile.

Dosage and Administration Information

Zanic (Zinc Sulfate) is administered through specific protocols for both oral and intravenous (IV) routes. These protocols define the required dose of elemental zinc, frequency, preparation, and specific use constraints to ensure standardized application.


Official Administration Guidelines

Instruction Detail
Route of Administration Oral (tablet, capsule, or solution) for supplementation and Intravenous (IV) for admixture into Total Parenteral Nutrition (TPN) solutions.
Standard Dosing Adult IV Maintenance: Typically 3 mg/day elemental zinc, with potential for increases based on gastrointestinal fluid loss. Oral Therapeutic: Regimens often range from 25 mg to 50 mg elemental zinc daily for deficiency correction.
Pediatric Dosing Oral Acute Use: 10 mg elemental zinc once daily for infants under six months; 20 mg elemental zinc once daily for children six months to five years. IV Use: Dosing is weight-based (mcg/kg/day) and individualized based on the patient's nutritional requirements.
Frequency & Duration Administered daily (IV or oral); oral acute courses are specified for 10 to 14 days.

Preparation and Procedural Rules

Oral forms can be taken with food to minimize gastric discomfort, although ingestion between meals is often recommended. Dispersible tablets must be fully dissolved in 5 ml of water or breast milk prior to administration. The IV solution is not for direct infusion; it must be diluted and admixed into the final TPN solution. A key instruction requires separating the oral dose by at least 2 to 4 hours from certain medications or foods (e.g., high-fiber items) to avoid reduced absorption. For pediatric use, if a dose is vomited within 30 minutes, it must be repeated.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zanic


Evidence for Use in Acute and Persistent Diarrhea

Zanic (Zinc Sulfate) was studied for its use in research exploring short-term symptom changes related to acute diarrhea, primarily focusing on its impact in children. Randomized Controlled Trials (RCTs) and large Meta-Analyses have been conducted during periods of increased symptom activity. Studies monitored several outcomes, such as the duration of diarrhea and stool frequency. Findings describe patterns observed in the studies where children who received the supplement was observed in some studies compared to those who received a control. However, data show patterns related to the population studied, with the most frequently described patterns observed in research involving children who were already considered malnourished or at high risk of deficiency. The certainty remains low regarding a consistent effect across every population subgroup due to documented study heterogeneity.


Evidence for General Zinc Deficiency Correction


The research foundation supporting Zanic for correcting a systemic or functional imbalance involves regulatory reviews and long-term observational settings. Studies explored how the body’s zinc levels, measured in the blood, evolved in the observed populations following supplementation. Findings indicate that in patients with a confirmed zinc deficiency, supplementation was associated with the restoration of these circulating levels toward the target range. This evidence contributes to understanding symptom patterns related to the use of Zanic in the context of observed deficiency. The results apply only to the populations studied—specifically, those confirmed as deficient. For individuals whose zinc levels are within the normal range, the evidence is limited to suggest a generalized systemic or functional imbalance benefit beyond basic mineral repletion.


What Remains Uncertain About Zanic's Evidence


One key limitation is that many positive findings apply only to the populations studied, namely those with confirmed zinc deficiency or those living in deficiency-prone environments. For individuals whose zinc levels are already adequate, comparative evidence is lacking to suggest a clear, measurable systemic or functional imbalance benefit. Furthermore, evidence quality varies across studies, leading to mixed findings on specific numerical outcomes. Long-term effects are not fully established for regular, non-deficiency-related supplementation. These research limitations confirm that the evidence provides consistent data for deficiency correction but remains insufficient for generalized health promotion in well-nourished, stable populations.

Frequently Asked Questions (FAQ)

Common questions about Zanic (FAQ)


Q: Can Zanic be taken with common over-the-counter pain relievers?

Official documentation specifies the administration timing required for medicines known to chelate (bind) with Zanic, primarily certain antibiotics and chelating agents. Separation is generally not specified for common non-interacting over-the-counter pain relievers like acetaminophen or ibuprofen.


Q: Why do some people say Zanic made them feel tired?

Symptoms such as fatigue (feeling tired) or lethargy have been documented as potential adverse effects in official medical reports. These effects have been documented in association with high intake or zinc toxicity, but are less common with recommended therapeutic doses.


Q: How long is a typical course of treatment with Zanic?

The length of treatment is defined by the underlying health need. For acute conditions, international guidelines often specify a short duration, such as 10 to 14 days. For the correction of a confirmed deficiency, consistent supplementation may be needed for several months under a healthcare professional's guidance.


Q: Is it normal to feel a change in appetite after starting Zanic?

According to official product information, a loss of appetite is one of the potential adverse effects that has been documented. This change has been documented in association with high intake of zinc supplements.


Q: Is there a generic version of Zanic available?

Yes, Zanic is a brand name for the active ingredient, Zinc Sulfate. Zinc Sulfate is a globally recognized medicine available in both brand-name forms and as a generic product. Some lower-dose forms of Zinc Sulfate may be available over-the-counter.


Q: Why are there different strengths or forms of Zanic?

The medication is available in various forms, including oral tablets, capsules, and an IV solution. These different forms and strengths are provided to accommodate varying administration routes—such as oral digestion versus intravenous (IV) feeding—and to meet the specific elemental zinc requirements of different age groups or medical conditions.


Q: What kind of studies support the use of Zanic?

The evidence supporting Zanic comes from studies, including Randomized Controlled Trials (RCTs) and systematic reviews, recognized by health authorities. These studies have primarily focused on its use in specific patient populations, such as children with acute conditions and individuals diagnosed with a confirmed zinc deficiency.


Q: How quickly do people typically start noticing the effects of Zanic?

Zanic is a mineral supplement intended to restore systemic zinc levels, which is a process that takes time. The speed of change is dependent on the individual's initial deficiency status, but the objective of normalizing plasma zinc levels can require consistent use over a period of weeks to months.


Q: What happens if a dose of Zanic is missed?

If a dose is forgotten, the general recommendation is to take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, official guidance often suggests skipping the missed dose to prevent taking doses too close together.


Q: Is it okay to have alcohol while taking Zanic, according to official documents?

Official product documentation for Zanic (Zinc Sulfate), which is a mineral supplement, does not contain a specific warning or precaution regarding the co-administration or consumption of alcohol.


Q: Are there any warnings about driving or operating machinery while taking Zanic?

Official product information for Zanic does not typically include warnings against driving or operating machinery. This is because the medication is a mineral supplement and is not known to cause the Central Nervous System (CNS) depressant effects that necessitate such cautions.


Q: How does Zanic compare generally to other treatments for the same condition?

Regulatory bodies classify Zanic as a mineral supplement and a trace element. Its core role is restorative, aiming to correct or prevent a nutritional deficiency. This function is fundamentally different from that of pharmacological agents, which act through inhibitory or stimulatory mechanisms.


Q: Does Zanic require a special diet or monitoring?

Zinc absorption can be affected by food, and certain foods should be separated from the dosing time to avoid reduced absorption of the medication. Monitoring of the body's mineral levels (like zinc and copper) is sometimes performed, and may be indicated by official guidelines, especially during prolonged use or in patients with pre-existing conditions like kidney impairment.


Q: Is Zanic commonly associated with stomach upset?

Gastrointestinal upset is a commonly reported adverse reaction documented in official sources. Symptoms can include nausea, vomiting, diarrhea, and stomach pain. These effects have been documented in association with taking high doses or taking the supplement on an empty stomach.


Q: Are headaches a common side effect listed for Zanic?

Yes, official adverse event profiles document that headache is a potential adverse effect. It is a symptom that has been noted, particularly in cases of high zinc intake or signs of toxicity.


Q: What do clinical studies say about the long-term effectiveness of Zanic?

Clinical evidence is most consistent regarding Zanic's ability to correct a confirmed zinc deficiency and for short-term use in specific acute conditions. Regulatory reviews indicate that there is limited evidence to support generalized long-term systemic benefits in individuals whose zinc levels are already adequate.


Q: Is the medication designed to be taken at a specific time of day?

Official guidance emphasizes the importance of regular daily administration for consistency and compliance. While it is generally recommended to take the medication at the same time each day, there is typically no mandatory requirement specifying a morning or nighttime dose.


Q: Does the efficacy of Zanic change if I weigh more or less?

Dosing for specific groups, such as children receiving intravenous (IV) nutrition, is precisely calculated based on the patient's body weight. However, standard oral adult doses are typically set based on the severity of the deficiency and are not usually adjusted based on a person's routine weight fluctuations.


Q: Are there any specific mood changes officially noted as potential side effects of Zanic?

Mood changes, such as depression, have been documented in association with states of excessive zinc intake or toxicity. These are not typically listed as common adverse reactions at standard therapeutic doses.


Q: Is Zanic considered a high-risk medication?

Health authorities categorize Zanic as a trace element (mineral supplement), and it is included on the WHO List of Essential Medicines. While it is not typically categorized as 'high-risk,' specific precautions are listed for patients with certain pre-existing conditions, such as kidney impairment.


Q: Why do official documents state Zanic should be stopped under certain conditions?

Official guidelines describe the need for cessation, primarily if a patient experiences a hypersensitivity (allergic reaction) to the drug. Cessation is also described in situations of excessive intake that could lead to toxicity and complications, such as an induced copper deficiency.


Q: Is Zanic known to interact with blood pressure medications?

Official drug interaction information documents potential interactions with certain types of blood pressure medications. For example, some diuretics can increase zinc excretion, and ACE inhibitors may also have specific requirements, which may necessitate monitoring as determined by a healthcare professional.


Q: What kind of professional advice is recommended before starting Zanic?

Health authorities consistently recommend consulting a healthcare professional before starting Zanic. This is especially important if you are taking other medications, have pre-existing medical conditions (like kidney dysfunction), or are pregnant or nursing.


Q: Is a prescription always required to get Zanic?

The legal status of Zanic (Zinc Sulfate) varies based on the formulation and dose. It is available in various forms, with some high-strength or specialized formulations being prescription-only (Rx), while lower-dose oral forms may be available over-the-counter (OTC).


Q: What are the typical non-serious side effects of Zanic?

The non-serious side effects most commonly documented in official reports relate to the digestive system. These include nausea, stomach pain, vomiting, and diarrhea, particularly when the dose is high or if the medication is taken on an empty stomach.

How should Zanic be stored and disposed of?

How to Store and Dispose of Zanic?

The storage and disposal of Zanic (Zinc Sulfate) must strictly follow official labeling to maintain product stability and ensure safety.

Storage Requirements

Zanic must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), and must be protected from excessive moisture.

Storage Condition Requirement
Container Keep in the original container and keep it tightly closed.
Freezing Do not freeze the medicine.
Child Safety Must be kept out of the sight and reach of children.

️ Disposal Instructions

Unused or expired Zanic should be disposed of through an authorized drug take-back program. If a program is unavailable, the product must be mixed with an unappealing substance (like dirt or coffee grounds), placed in a sealed container, and then discarded in the household trash. The medicine must not be thrown into wastewater unless specifically instructed by regulators.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zanic found in:

A-Z Index: